Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Key Factors to Evaluate Before Investing in PAYX

Shares of Industrials sector company Paychex moved -0.2% today, and are now trading at a price of $124.55. The Large-Cap stock's daily volume was 3,295,433 compared to its average volume of 2,597,742. The S&P 500 index returned a 1.0% performance.

Paychex, Inc., together with its subsidiaries, provides human capital management solutions (HCM) for payroll, employee benefits, human resources (HR), and insurance services for small to medium-sized businesses in the United States, Europe, and India. The company is based in Rochester and has 19,000 full time employees. Its market capitalization is $44,824,817,664. Paychex currently offers its equity investors a dividend that yields 3.3% per year.

14 analysts are following Paychex and have set target prices ranging from $122.0 to $150.0 per share. On average, they have given the company a rating of hold. At today's prices, PAYX is trading -7.74% away from its average analyst target price of $135.0 per share.

Over the last year, PAYX shares have gone down by -11.1%, which represents a difference of -27.1% when compared to the S&P 500. The stock's 52 week high is $161.24 per share and its 52 week low is $119.02. With average free cash flows of $1.49 Billion that have been growing at an average rate of 6.8% over the last 5 years, Paychex declining stock performance may not be reflective of the quality of its underlying business.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 1,900,900 191,800 1,709,100 -1.57
2023 1,897,700 161,400 1,736,300 11.07
2022 1,706,200 143,000 1,563,200 7.37
2021 1,589,700 133,800 1,455,900 27.5
2020 1,260,300 118,400 1,141,900 -13.09
2019 1,440,900 127,000 1,313,900
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS